When                                   8:00 am - 4:00 pm, Saturday, November 3rd, 2012

Where                                 Institute of Americas, UCSD

Registration                   https://www.123signup.com/register?id=snyvs

$20 online（$10 for students and post-docs）before Nov 1st. $40 onsite.

Registration fee includes parking, program brochure, breakfast, coffee, and lunch.

The global IVD market was valued at $44 billion in the year 2011, growing at a CAGR of 7.8% from 2011 to 2016. Advancements in molecular technology, personalized medicine, point of care testing and a competitive landscape are the major drivers improving clinical decisions contributing to improved patient care. This forum offers a comprehensive view of the innovations and challenges of the diagnostics industry and a platform of opportunity to interact with leaders in this field. Come hear from key players from industry and academics share their experience and vision on next generation sequencing, CLIA testing, proteomics, marketing & sales strategy, IP issues related with gene testing and contract development and manufacturing. 

Agenda

8:00                     Registration

8:50                     Opening Remarks

9:00                     Keynote：Paul Billings, M.D. Ph.D. “Repersonalizing Mecicine”

CMO, Life Technologies

9:45                     Jonathan Diver, Ph.D. “The Business of InVitro Diagnostics：Regulations, CLIA Operations, and Financial Complications” Senior VP of Lab Operations, Genoptix, a Novartis Company

10:15                  Coffee Break

10:30                  Peter Simpson, “Building a Platform for Success：Leading Glucose Sensor Technologies for Diagnostic and Therapeutic Applications” Senior Director of R&D, Dexcom

11:00                  Heather Devereaux, “Information Trends Driving Device and Diagnostic Breakthroughs”

Customer Engagement Team Manager, Elsevier

11:15                  Andrew Wang, Ph.D. “Nanoparticles for Biomedical Device and Diagnostics”

President, Ocean NanoTech

11:30                  David K. Stelter, “Think Global -  Act Local”

VP of Business Development, BIT MedTech     

11:45                  Lunch

1:30                    Bing Ren, Ph.D. “Epigenetic Signatures of Cell States”

Professor, Department of Cellular and Molecular Medicine, UCSD

2:00                    Peng Chen, Ph.D. “America Invents Act – Challenges and Opportunities”

Partner, Morrison & Foerster

2:30                    Panel Discussion：A New Paragdigm in the Contract Manufacturing of Diagnostic Devices and Emerging Point of Care Technologies

Moderator      Caroline Cheung, President, Allied Intrade

Panelists          Brian Kelleher, Managing Partner, Tigris Ventures

Alex Kunczynski, President, D&K Engineering

Michelle Lum, Deputy General Manager, Automatic Manufacturing Limited

Junquan Xu, COO, CapitalBio

3:30                        Closing Remarks